Shelley K. Ballentine

JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia

Carl L. Manthey, Dana L. Johnson, Carl R. Illig et al. · Molecular Cancer Therapeutics · 2009 · 107 citations

Solid Tumors, Immunology, Cancer Biology +17

Design and Optimization of Benzimidazole-Containing Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists

Daniel J. Parks, William H. Parsons, Raymond W. Colburn et al. · Journal of Medicinal Chemistry · 2010 · 65 citations · Full text

Vivo Antagonism, Drug Target, Pain Medicine +19

Discovery of novel FMS kinase inhibitors as anti-inflammatory agents

Carl R. Illig, Jinsheng Chen, Mark J. Wall et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 51 citations · Full text

Inflammation, Anti-inflammatory, Anti-inflammatory Agents +7

Acridone-Based Inhibitors of Inosine 5‘-Monophosphate Dehydrogenase:  Discovery and SAR Leading to the Identification of <i>N</i>-(2-(6-(4-Ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419)

Scott H. Watterson, Ping Chen, Yufen Zhao et al. · Journal of Medicinal Chemistry · 2007 · 49 citations · Full text

Sar Leading, Pharmaceutical Science, Inosine 5 +17

Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors

Mark J. Wall, Jinsheng Chen, Sanath K. Meegalla et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 47 citations · Full text

Novel 3,4,6-Substituted 2-Quinolones, Combinatorial Chemistry, Medicinal Chemistry +9